These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 7908422

  • 21. Growth hormone releasing activity persists in the deafferented medial-basal hypothalamus of the rat.
    Antoni FA, Makara GB, Rappay G.
    J Endocrinol; 1981 Dec; 91(3):415-25. PubMed ID: 6120201
    [Abstract] [Full Text] [Related]

  • 22. Evidence that catecholaminergic and peptidergic (luteinizing hormone-releasing hormone) neurons in suprachiasmatic-medial preoptic, medial basal hypothalamus and median eminence are involved in estrogen-negative feedback.
    Advis JP, McCann SM, Negro-Vilar A.
    Endocrinology; 1980 Oct; 107(4):892-901. PubMed ID: 6997020
    [Abstract] [Full Text] [Related]

  • 23. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J, Müller OA, Schopohl J, von Werder K.
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [Abstract] [Full Text] [Related]

  • 24. Hypothalamic derangement in traumatized patients: growth hormone (GH) and prolactin response to thyrotrophin-releasing hormone and GH-releasing hormone.
    De Marinis L, Mancini A, Valle D, Bianchi A, Gentilella R, Liberale I, Mignani V, Pennisi M, Della Corte F.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):741-7. PubMed ID: 10468946
    [Abstract] [Full Text] [Related]

  • 25. Pituitary and extrapituitary action sites of the novel nonpeptidyl growth hormone (GH) secretagogue L-692,429 in the chicken.
    Geris KL, Hickey GJ, Berghman LR, Visser TJ, Kühn ER, Darras VM.
    Gen Comp Endocrinol; 1998 Aug; 111(2):186-96. PubMed ID: 9679090
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H, Suzuki M.
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [Abstract] [Full Text] [Related]

  • 29. The rat posterior pituitary contains a potent prolactin-releasing factor: studies with perifused anterior pituitary cells.
    Hyde JF, Murai I, Ben-Jonathan N.
    Endocrinology; 1987 Oct; 121(4):1531-9. PubMed ID: 2888647
    [Abstract] [Full Text] [Related]

  • 30. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
    Sato M, Frohman LA.
    Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097
    [Abstract] [Full Text] [Related]

  • 31. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A, Epelbaum J, Arancibia S, Tapia-Arancibia L, Bluet-Pajot MT, Kordon C.
    Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Diisopropylfluorophosphate (DFP) reduces serum prolactin, thyrotropin, luteinizing hormone, and growth hormone and increases adrenocorticotropin and corticosterone in rats: involvement of dopaminergic and somatostatinergic as well as cholinergic pathways.
    Smallridge RC, Carr FE, Fein HG.
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):284-95. PubMed ID: 1673267
    [Abstract] [Full Text] [Related]

  • 34. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Changes in parathyroid hormone and calcium levels after superior cervical ganglionectomy of rats.
    Cardinali DP, Ladizesky MG.
    Neuroendocrinology; 1985 Apr; 40(4):291-6. PubMed ID: 3990913
    [Abstract] [Full Text] [Related]

  • 38. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
    Timmerman W, Poelman RT, Westerink BH, Schuiling GA.
    Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.